SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending due to positive Phase 3 trial results for its Duchenne muscular dystrophy (DMD) treatment, reigniting hopes for FDA approval. Community members are celebrating the potential for a first-in-class therapy and discussing the possibility of a short squeeze, with some analysts raising price targets significantly.

Carvana Co. is a holding company and an eCommerce platform, which engages in the buying and selling of used cars. The company was founded by Ernest Garcia, III, Benjamin Huston and Ryan Keeton in 2012 and is headquartered in Tempe, AZ.

Carvana Co. - Ordinary Shares - Class A

Carvana Co.

Carvana's recent price surge has sparked heated debate, with many questioning the company's valuation amid high debt and a challenged used car market. Community chatter revolves around whether the stock is primed for a correction or if it will continue its upward momentum, possibly driven by short squeezes and speculative trading. Bears cite fundamental concerns and potential market manipulation, while bulls point to technical indicators and analyst upgrades.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is trending as discussions revolve around its potential role in AI infrastructure, particularly after Marvell's acquisition of Celestial AI, a company using POET's technology. The community is analyzing potential impacts on POET's revenue and partnerships, speculating on future purchase orders or even a potential acquisition. Bullish sentiment is fueled by the belief that POET's technology is essential for next-generation data centers and AI applications.

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

Intuitive Machines ($LUNR) is trending as investors eagerly await news on the NASA Lunar Terrain Vehicle (LTV) contract award, with some speculating an announcement is imminent. Community discussions also highlight a recent insider buy and the company's acquisition of Lanteris Space Systems, contributing to bullish sentiment despite market volatility and concerns about short interest. Some are looking ahead to future catalysts, such as the IM-3 mission.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is trending amid ongoing speculation and bidding wars with Warner Bros. Discovery ($WBD), with investors assessing the potential impact of a deal. The community is actively debating whether acquiring $WBD would be a positive move, and whether the company should focus on organic growth instead.

Altimmune, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. The company's lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and NASH. In addition, Altimmune is developing HepTcell, an immunotherapeutic designed to achieve a functional cure for chronic hepatitis B. The company was founded in 1997 and is headquartered in Gaithersburg, MD.

Altimmune Inc

Altimmune is trending as the community discusses a new CEO appointment and what it signals for the company's strategic direction, with potential implications for partnerships or a buyout. Community members are analyzing the new CEO's background and compensation package, speculating on the timing of upcoming data releases, and assessing the impact on the company's future. The conversation also includes discussion around a potential price target increase by Piper Sandler.

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.

Aurinia Pharmaceuticals Inc

AUPH is trending due to a recent analyst upgrade from Jefferies, with a significantly increased price target fueling speculation. The community is buzzing about potential buyout scenarios and the implications of recent institutional activity, including Tang Capital's increased stake. Broader discussions involve the company's growth potential, pipeline prospects, and ongoing speculation about a potential acquisition.

Serve Robotics, Inc. engages in providing self-driving delivery. It designs, develops, and operates zero-emissions robots that serve people in public spaces, starting with food delivery. The company was founded by Ali Kashani, Dmitry Demeshchuk and MJ Burk Chun in 2017 and is headquartered in Redwood City, CA.

Serve Robotics Inc

SERV is trending as the community discusses the potential impact of a possible executive order from the Trump administration to bolster the robotics industry. Chatter revolves around the stock's potential to fill gaps and reach higher price levels. Some investors are expressing confidence in the company's long-term prospects and partnerships.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending amidst community excitement surrounding potential catalysts like Michael Burry's promised GME story and anticipation for upcoming earnings, with sentiment boosted by a recent significant buy order. Despite some skepticism about immediate price movement and ongoing manipulation concerns, the community remains focused on the company's fundamentals, including its cash position and transformation strategy. Discussions also revolve around warrants and potential for a squeeze, as well as the possible influence of key figures like Ryan Cohen.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is trending due to refuted reports of lowered AI sales quotas, sparking debate about the company's AI prospects and market manipulation. The community is discussing the validity of the news, potential recovery, and its impact on long-term investment strategies. Some are concerned about the manipulation surrounding MSFT and OpenAI, while others see the dip as a buying opportunity.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Magnetar Financial LLC Buys 64,345 Shares of Kura Oncology, Inc. $KURA

Magnetar Financial LLC grew its stake in Kura Oncology, Inc. (NASDAQ:KURA - Free Report) by 536.9% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and...

Interesting KURA Put And Call Options For July 2026

Investors in Kura Oncology Inc (Symbol: KURA) saw new options begin trading this week, for the July 2026 expiration. One of the key inputs that goes into the price an option buyer is willing to pay...

Kura Oncology, Inc. (NASDAQ:KURA) Receives Average Recommendation of "Moderate Buy" from Analysts

Shares of Kura Oncology, Inc. (NASDAQ:KURA - Get Free Report) have earned a consensus recommendation of "Moderate Buy" from the fifteen research firms that are covering the firm, Marketbeat Ratings...

Los Angeles Capital Management LLC Acquires Shares of 77,958 Kura Oncology, Inc. $KURA

Los Angeles Capital Management LLC purchased a new position in shares of Kura Oncology, Inc. (NASDAQ:KURA - Free Report) during the second quarter, according to the company in its most recent Form...

Savant Capital LLC Increases Position in Kura Oncology, Inc. $KURA

Savant Capital LLC increased its position in Kura Oncology, Inc. (NASDAQ:KURA - Free Report) by 74.1% in the second quarter, according to its most recent 13F filing with the Securities and Exchange...

Insider Selling: Kura Oncology (NASDAQ:KURA) SVP Sells 4,539 Shares of Stock

Kura Oncology, Inc. (NASDAQ:KURA - Get Free Report) SVP Thomas James Doyle sold 4,539 shares of the company's stock in a transaction that occurred on Friday, November 14th. The shares were sold at an...

Kathleen Ford Sells 6,902 Shares of Kura Oncology (NASDAQ:KURA) Stock

Kura Oncology, Inc. (NASDAQ:KURA - Get Free Report) COO Kathleen Ford sold 6,902 shares of the firm's stock in a transaction dated Friday, November 14th. The shares were sold at an average price of...

Teresa Brophy Bair Sells 8,804 Shares of Kura Oncology (NASDAQ:KURA) Stock

Kura Oncology, Inc. (NASDAQ:KURA - Get Free Report) insider Teresa Brophy Bair sold 8,804 shares of the business's stock in a transaction that occurred on Friday, November 14th. The shares were sold...

Kura Oncology (NASDAQ:KURA) Insider Brian Powl Sells 8,887 Shares

Kura Oncology, Inc. (NASDAQ:KURA - Get Free Report) insider Brian Powl sold 8,887 shares of the firm's stock in a transaction dated Friday, November 14th. The shares were sold at an average price of...

Kura Oncology (NASDAQ:KURA) Insider Mollie Leoni Sells 15,485 Shares

Kura Oncology, Inc. (NASDAQ:KURA - Get Free Report) insider Mollie Leoni sold 15,485 shares of Kura Oncology stock in a transaction that occurred on Friday, November 14th. The stock was sold at an...

Kura Oncology, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the research and development of medicines for the treatment of cancer. Its pipeline includes Tipifarnib, which is a Farnesyl transferase inhibitor for HRAS Mutant Solid Tumors, Chronic Myelomonocytic Leukemia, KO-947, which is an ERK inhibitor for MAPK Pathway Tumors, and KO-539, which is a Menin MLL inhibitor for acute leukemias. The company was founded by Troy E. Wilson, Yi Liu, Pingda Ren and Antonio Gualberto on August 22, 2014 and is headquartered in San Diego, CA.

Current Price	$12.08
Prev Close	$11.13
Open	$11.29
Dividend Yield	0.00%
50-Day Moving Average	$10.16
Beta	0.99
Avg. Volume	2.17M
PE Ratio	-4.49

52-Week High	$12.49
52-Week Low	$5.41
Market Capitalization	$968.5M
EPS (Annual)	-$2.02
Price to Book	3.99
Revenue Per Employee	$280,640.63
Enterprise Value/EBITDA	N/A

KURA
Kura Oncology Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest KURA News

KURAKura Oncology Inc